Ethyol

Active Ingredient(s): Amifostine
FDA Approved: * December 8, 1995
Pharm Company: * MEDIMMUNE ONCOLOGY
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ethyol Overview

Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. Contents 1 Indications 2 Pharmacokinetics 3 Mechanism of action 4 Adverse effects 5 Contraindications 6 References Indications Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents includi...

Read more Ethyol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amifostine

Recent Ethyol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amifostine
  • Injection: 375mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ethyol: (1 result)

Sorted by National Drug Code
  • 66220-017 Ethyol 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Cumberland Pharmaceuticals Inc.

Other drugs which contain Amifostine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA